Key facts
- This page summarizes Andrew Emerson's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Aug 2026, 17:00.
Andrew Emerson - 20 Aug 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- EVP, CFO and Treasurer
- Issuer ticker
- IDXX
- Reported as of
- 20 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Aug 2026, 17:00:10 UTC
- Prior SEC filing
- 17 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Andrew Emerson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Andrew Emerson filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 24 Aug 2026.
Change
- Previous filing in this sequence was filed on 17 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002058587
Primary reporting owner
Emerson Andrew
- Relationship
- EVP, CFO and Treasurer
- Address
- ONE IDEXX DRIVE, WESTBROOK
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Andrew Emerson
- Signature date
- 24 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +265
- Change %
- +6.2%
- Price
- $178.26*
- Shares after
- 4,507
- Date
- 20 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
IDXX
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -86
- Change %
- -1.9%
- Price
- $0.000000*
- Shares after
- 4,421
- Date
- 20 Aug 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Incentive Stock Option (right-to-buy)
Options Exercise
- Transaction value
- Shares
- -265
- Change %
- -22%
- Price
- Shares after
- 925
- Date
- 20 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 265
- Exercise price
- $178.26
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes a total of 20 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2026 and June 30, 2026.
Footnote F2
Grant of option to buy 1,190 shares of Issuer common stock that became exercisable in one installment on February 14, 2023.
Footnote F3
Not applicable